G1 Therapeutics, Inc. (GTHX)
Sep 18, 2024 - GTHX was delisted (acquired by Pharmacosmos)
7.15
0.00 (0.00%)
Inactive · Last trade price on Sep 17, 2024
G1 Therapeutics Revenue
G1 Therapeutics had revenue of $16.55M in the quarter ending June 30, 2024, a decrease of -60.97%. This brings the company's revenue in the last twelve months to $58.20M, down -34.73% year-over-year. In the year 2023, G1 Therapeutics had annual revenue of $82.51M with 60.84% growth.
Revenue (ttm)
$58.20M
Revenue Growth
-34.73%
P/S Ratio
6.40
Revenue / Employee
$581,950
Employees
100
Market Cap
378.17M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 82.51M | 31.21M | 60.84% |
Dec 31, 2022 | 51.30M | 19.83M | 62.98% |
Dec 31, 2021 | 31.48M | -13.81M | -30.49% |
Dec 31, 2020 | 45.29M | - | - |
Dec 31, 2019 | - | - | - |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2014 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionGTHX News
- 1 year ago - Pharmacosmos Group and G1 Therapeutics Announce Successful Closing of Tender Offer - GlobeNewsWire
- 1 year ago - Pharmacosmos Group and G1 Therapeutics Announce Expiration of Hart-Scott-Rodino Waiting Period - GlobeNewsWire
- 1 year ago - G1 THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of G1 Therapeutics, Inc. - GTHX - Business Wire
- 1 year ago - SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates GTHX, PETQ on Behalf of Shareholders - GlobeNewsWire
- 1 year ago - G1 Therapeutics Provides Second Quarter 2024 Financial Results and Operational Highlights - GlobeNewsWire
- 1 year ago - Pharmacosmos Group to Acquire G1 Therapeutics - GlobeNewsWire
- 1 year ago - G1 Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 1 year ago - G1 Therapeutics to Release Second Quarter 2024 Financial Results and Provide Business Update on August 8, 2024 - GlobeNewsWire